fbpx

Australian Cancer Research Foundation Launches Liquid Biopsy Program for Children with Cancer

A “game-changing” liquid biopsy program, the first of its kind in Australia, is set to provide clinicians access to an important and innovative tool for monitoring treatment responses and predicting relapse in children with cancer.

Each year more than 1000 Australian children and young people are diagnosed with cancer. Accurate diagnosis of their cancer is usually based on a surgical biopsy of the tumour – an invasive and sometimes high-risk procedure.

Once diagnosed, the child’s cancer requires constant evaluation to monitor the effectiveness of treatment and identify impending relapse. However, current approaches are not sensitive enough to effectively identify treatment failure in advance of relapse occurring, by which time it might be too late to introduce new treatments which could save a child’s life.

Repeated surgical biopsies, which could provide the information needed to more accurately monitor treatment response and determine the need for the introduction of alternate, more effective treatments, are neither practical nor ethical due to their invasive nature.

The Australian Cancer Research Foundation (ACRF) Child Cancer Liquid Biopsy Program, which officially launched today in Sydney, represents a revolution in cancer sampling and monitoring.

Using cutting edge science and technology the program uses a simple blood test to provide a window into the tumour throughout a child’s cancer journey, to obtain urgently needed information on treatment response and progression of the tumour.

This test can identify the presence and level of circulating tumour cells and/or tumour DNA in blood to monitor, with a high level of sensitivity, whether or not the child is responding well to treatment. It can also provide complex genetic information on the tumour that can be used to predict imminent relapse and guide subsequent treatment recommendations in real time.

Professor Michelle Haber AM, Executive Director of Children’s Cancer Institute, says this revolutionary approach to cancer sampling and monitoring has the potential to be a “game changer” for children diagnosed with high-risk cancers.

“Liquid biopsy is a hugely exciting development in cancer sampling, that has the potential to dramatically enhance our ability to make personalised treatment recommendations that give each child the best possible chance of survival. Currently, when a child is diagnosed with cancer all molecular information is collected from the initial surgical tumour biopsy, and that is used to guide treatment. But we know that the tumour cells can change their biology in response to therapy, so the treatment that is given at the start of the cancer journey may no longer be the best treatment as the tumour cells mutate. That is why patients often initially respond to treatment but subsequently relapse.

“Being able to take repeated blood samples, or “liquid biopsies”, to monitor the presence and the levels of cancer cells and cancer DNA in the blood over time, and to track genetic changes in the cancer, provides valuable information about the cancer, and can also reveal evidence of impending clinical relapse before it occurs. More importantly, the information acquired from the liquid biopsy, may suggest a better personalised treatment by identifying new molecular targets that have developed in the tumour as it mutates over time.” says Professor Haber.

Professor Haber says the ACRF liquid biopsy program will be critical in helping to improve not only the effectiveness and timeliness of treatments but in reducing the number of invasive procedures that children with cancer will have to undergo.

 “The safer and quicker the tests are, the more frequently they can be repeated to monitor the progress of the cancer most effectively,” she says.

The program launch has been made possible thanks to a $3.5 million grant awarded from ACRF to Children’s Cancer Institute in 2019 for cutting edge technology and equipment to monitor and analyse circulating tumour cells and tumour DNA with great sensitivity and specificity.

The ACRF Child Cancer Liquid Biopsy Program will initially focus on children with the following types of cancers:

  • Brain cancers
  • Blood cancers
  • Sarcoma
  • Neuroblastoma
  • Other extracranial solid cancers

ACRF’s CEO, Kerry Strydom says, “Australian Cancer Research Foundation backs brilliant cancer research and cutting-edge technology that drives innovation and save lives. The ACRF Child Cancer Liquid Biopsy Program is a wonderful example of how technology can improve the way we manage a cancer diagnosis and treatment.

“This new program will result in minimising the level of invasive testing that children with cancer need to undergo – a significant milestone in the treatment of childhood cancer, and could also lead to new therapies for some of the most difficult-to-treat and deadly childhood cancers, as well as improve the quality of life for those children that do survive.

“We are honoured to magnify our support to better prevent, detect and treat childhood cancers.” says Kerry.

The ACRF Child Cancer Liquid Biopsy Program has been further supported by Cancer Institute NSW, who have provided funding for technical specialists to work in this progressive and innovative lab.

What is Childhood Cancer?

Cancer is a disease of the cells. Cells divide and form new cells constantly throughout the body to replace old, or dead cells. Usually, cells divide and grow normally and will stop growing when they need to. Cancer starts when a cell becomes abnormal and grows and multiplies in an uncontrolled way.

The types of cancers that occur in children can be different from those that occur in adults. Childhood cancers:

  • can look different under the microscope
  • start in different parts of the body 
  • are treated differently
  • respond differently to treatment. 

Children often respond better to treatment than adults. This could be because:

  • the cancer itself is different
  • children may get more intense treatments
  • children don’t have any other health problems, or comorbidities (other health conditions), like many adults do

How many childhood cancers are there?

The types of cancers that affect children are usually different to the cancers that affect adults.

There are many forms of childhood cancers which tend to affect fast-growing tissues such as blood, lymph, bone marrow, nervous tissues, muscles, kidney, liver, and bone.

The most common childhood cancer types are; bone tumours, brain and other central nervous system tumours, germ cell tumours, Hodgkin lymphoma (Hodgkin disease), kidney (renal) tumours, leukaemia, liver tumours, melanoma, neuroblastoma, non-Hodgkin lymphoma, retinoblastoma and, soft tissue sarcoma. Read more about childhood cancer types here.

Are there specific symptoms to help you identify childhood cancer? 

Childhood cancer can often take longer to diagnose due to the symptoms being very similar to other medical conditions, including common infections. Because of this, children may need to undergo a variety of common tests to diagnose the cancer.

Specific symptoms to help identify childhood cancer include:

  • easy bruising, or bruising that doesn’t go away
  • an unusual lump, bump or swelling
  • unexplained paleness, tiredness, loss of energy and loss of interest
  • pain in one area of the body that doesn’t go away
  • limping or difficulties moving around
  • unexplained fever or illness that doesn’t go away
  • frequent headaches, often with nausea or vomiting
  • visual changes, such as blurred vision
  • lack of balance or direction when walking, that doesn’t go away
  • unexplained weight loss

If a child presents these symptoms, it does not mean they have cancer although if these symptoms don’t go away quickly, it is important to have a check-up with a doctor. 

What are the treatments for childhood cancer?

Treatment for childhood cancer depends on what type of cancer a child has been diagnosed with. When deciding treatment options, the side effects and potential risks, as well as the length of treatment, are also considered. A multidisciplinary team of health professionals are involved in planning and executing a child’s treatment.

Chemotherapy

Chemotherapy destroys or slows the growth of cancer cells through the use of specialised medicines. These medicines target fast-growing cells, which include cancer cells. There are many different types of chemotherapy medicines, however most children have combinations of different ones. This is to prevent the cancer cells becoming resistant to the medicines.

Radiation Therapy

Radiation therapy, also known as radiotherapy, uses radiation to kill or damage cancer cells. Doctors who specialise in radiation therapy for children will give the treatment to your child. These doctors are called paediatric radiation oncologists and follow international practice.

Infants and young children can have radiation therapy although chemotherapy is preferred. Radiation therapy is mainly used for older children or as an option after chemotherapy, if the cancer returns.

Stem cell transplant

A stem cell transplant is also known as a bone marrow transplant. A child’s doctor may recommend this treatment if the child has a blood cancer such as leukaemia, lymphoma, or high-risk neuroblastoma. Stem cell transplants involve destroying all the blood-forming cells in the child’s bone marrow, including cancer cells. The blood-forming cells are then replaced with healthy stem cells. These stem cells develop into new bone marrow and produce healthy blood cells.

Surgery

Surgery is one of the main treatments for childhood cancer. Doctors will usually only perform surgery for cancers that involve a lump or tumour. Surgery to remove a tumour involves making an incision in the skin. The doctor will remove as much of the tumour as possible. Minimally invasive surgery (also called keyhole surgery) can be used to help make a diagnosis and for treatment.

Can you prevent childhood cancer? 

It is not always clear why some children develop cancer, and others do not. In most cases, it is unknown as to why children get cancer and there is usually no form of prevention.

Sometimes tumours develop as a result of a genetic error which occurs while a child’s body is growing, and sometimes childhood cancers are genetic. Some children are born with genetic conditions that increase their chance of getting certain cancers, however this does not mean they will develop cancer. 

How can you help further research into childhood cancer? 

Making a donation is one of the best ways to help accelerate research and ultimately, transform the prevention, detection and treatment of childhood cancer.

Thanks to donations from our generous supporters, ACRF was able to award a $3.5 million grant to the Children’s Cancer Institute (CCI) in Sydney to establish the ACRF Child Cancer Liquid Biopsy Program. Currently, children with cancer must endure tumour biopsy – a painful and invasive procedure that provides limited information about the different types of cancer cells in the tumour at a point in time. This program will help develop a more sensitive and less invasive type of sampling, based on a child’s blood or lymph fluid – a game-changer for children diagnosed with cancer, and their families. Read more about the grant here.

Donate Today to help ACRF back brilliant cancer research

ACRF is committed to backing the brilliant ideas needed to find new ways to prevent, detect and treat all types of cancer, including childhood cancer, so that we can reach our vision of a world without this devastating disease.

By donating to ACRF, you are helping to provide scientists with the tools, technology and infrastructure they need to accelerate cancer research. Click here to see donation options or make a donation today.

Sources:

What is Melanoma?

Melanoma is a cancer that begins in the melanocytes – a cell that produces and contains the pigment called melanin. Most melanoma cells still make melanin, and so melanoma tumours are usually brown or black, but they can also appear pink, tan or even white. 

The most common locations for melanomas are chest and back for men, and legs for women. The face and neck are also common sites for melanoma, though they can form elsewhere.

Melanoma is much less common than Basal Cell and Squamous Cell skin cancers. Melanoma is the most dangerous form of skin cancer because if it isn’t detected early, it can spread to other organs. For that reason, early diagnosis is key. While an individual with stage 1 melanoma has a 99% chance of surviving longer than five years, that figure drops dramatically if the cancer spreads. Individuals with stage 4 melanoma have just a 20% chance of surviving longer than five years.

The most important symptom for melanoma is a new spot on the skin or a spot that is changing in size, shape, or colour. Other signs to look for are:

  • One half of a mole or birthmark that does not match the other.
  • The edges are irregular, ragged, notched, or blurred.
  • The colour is not the same all over and may include shades of brown or black, or sometimes with patches of pink, red, white, or blue.
  • The spot is larger than 6mm across, although melanomas can sometimes be smaller than this.
  • The mole is changing in size, shape, or colour.

What is melanoma caused by?

Generally, melanoma is caused by an overexposure of UV radiation – each time the skin is exposed to UV radiation from the sun or artificial sources such as tanning beds, changes take place in the structure of cells. Too much radiation causes the skin to become permanently damaged – this will worsen with each exposure.

Who is most at risk of melanoma?

Melanoma is Australia’s ‘national cancer’, with our population experiencing this cancer at 12 times the rate of global incidence. 

A few factors that may put some people more at risk of melanoma are:

  • A family history of melanoma.
  • A history of skin cancer.
  • Age – studies have shown that people over 50 may be at increased risk of melanoma.
  • Skin colour – people with lighter skin are at a higher risk of developing melanoma.

Innovative solutions for the early detection of melanoma are vital to saving lives. 

Thanks to our supporters, Australian Cancer Research Foundation awarded $10 million to establish the Australian Centre of Excellence in Melanoma Imaging and Diagnosis (ACRF ACEMID) project. The project includes the rollout of 15 three dimensional total body imaging systems across Queensland, New South Wales and Victoria to significantly enhance the capability and capacity of clinicians and researchers to detect and understand melanoma.

Can you prevent melanoma?

You can lower your risk of developing melanoma through the following activities:

  • Avoiding intentionally exposing your skin to the sun – especially through activities such as tanning.
  • Wear protective clothing such as long sleeves and polarised sunglasses.
  • Make wearing sunscreen a daily habit. A broad spectrum sunscreen which protects from both UVA and UVB rays should be reapplied every two hours when your skin is exposed to sun.
  • Avoid peak times of 12pm-2pm when the sun is at its highest, seek shade during these periods.

Is melanoma hereditary?

The risk of melanoma can be passed from generation to generation by either having a genetic predisposition to the cancer, or by inheriting traits such as pale skin that burns easily. It could also be increased by family shared lifestyle factors such as frequent sun exposure. 

Your risk of melanoma is higher if one or more of your immediate family members has had melanoma, but it is not a certainty that you develop this cancer. 

What is Mohs surgery for melanoma?

Mohs surgery is a treatment often used for treating skin cancers such as basal cell carcinomas and squamous cell carcinomas. It is less common for treating melanoma but can be effective. The procedure is relatively simple and fast and doesn’t require a patient to go under general anaesthesia. 

By supporting Australian Cancer Research Foundation, you’re helping provide the brightest minds in our country with the tools they need to prevent, detect and treat all types of cancer. Your support is integral in bringing us closer to a world without cancer. Help Back Brilliant cancer research – donate today

What are the different types of Cancer Treatment?

Cancer can be treated in many different ways. The form of treatment is recommended by a health professional and depends on the type of cancer, how advanced it is, and other personal factors.

Chemotherapy

Chemotherapy involves the use of specialised drugs to kill or slow the growth of cancer cells. Chemotherapy can be used on its own or in combination with other types of treatment. Your health practitioner may recommend chemotherapy to shrink a tumour before surgery, to destroy remaining cancer cells after surgery, or to improve symptoms and prolong life, when it is not possible to treat the cancer.

Chemotherapy is often used to treat ovarian cancer, and is usually required alongside surgery. Chemotherapy treatment is given under the guidance of a medical oncologist, and depends on the type and stage of the ovarian cancer and the women’s general health. 

Radiation therapy 

Radiation therapy is the use of x-rays (radiation) to destroy or injure cancer cells so they cannot multiply. Similarly to chemotherapy, radiotherapy can be used on its own or in combination with other treatment methods. 

Radiation therapy is often used to treat bowel cancer. Bowel cancer occurs when abnormal cells in the wall of the large intestine grow in an uncontrolled way. Radiation therapy is usually used when surgery is required, depending on the stage and location of the cancer.

Other types of cancers that are treated with radiation therapy include lung cancer and brain cancer.

Surgery

Surgery is the most common type of treatment for many cancers, especially when the tumour is localised. Generally, the cancer along with normal tissue (a margin) is removed to ensure that there are no microscopic traces of the tumour remaining. Surgery can be undertaken for a range of reasons, including to diagnose the tumour, and to remove the tumour. Surgery can also be used as a combination treatment to remove as much of the tumour as possible prior to further treatment, or as a palliative option to relieve symptoms. 

Breast cancer is a form of cancer that uses surgery as a main form of treatment. In patients with breast cancer, abnormal cells develop in the breast and form tumours which invade the surrounding breast tissue. Surgery is used to remove part or all of the affected breast tissues, as well as one or more lymph nodes from the armpit. 

Lung cancer and brain cancer are two other types of cancer that primarily use surgery as a form of cancer treatment. 

Immunotherapy 

Immunotherapy is a treatment that uses certain parts of a person’s immune system (a collection of organs, special cells and substances that help protect from infections and some other diseases) to treat cancer. Immunotherapies are thought to work by slowing the growth and spread of cancer cells, and by helping the immune system destroy existing cancer cells.

Immunotherapy can be given in multiple ways which includes oral or liquid form, as pills or tablets, intravenously through an injection into a vein, topically, as a cream, or intravesically, administered into the bladder. 

The main types of immunotherapy treatments are monoclonal antibodies, nonspecific immunotherapies, and cancer vaccines. Chronic lymphocytic leukaemia uses monoclonal antibodies which attach to cancer cells, directing the immune system to destroy specific cells.

Stem Cell Transplant

A stem cell transplant replaces blood-forming cells within bone marrow, including the cancer cells, that have been destroyed by chemotherapy with healthy stem cells. These cells develop into new bone marrow and produce healthy blood cells. A stem cell transplant can use your own stem cells (autologous transplantation) or stem cells from a donor (allogeneic transplantation). 

This treatment may be recommended for people with blood cancers such as leukaemia, myeloma or lymphoma.

Bone Marrow Transplant 

A bone marrow transplant is very similar to a stem cell transplant. Instead of replacing blood-forming cells in your bone marrow, a bone marrow transplant uses stem cells from your bone marrow instead of your bloodstream. This form of treatment is also recommended for people with blood cancers such as leukaemia, myeloma or lymphoma.

Cancer Treatment Research

Every year more than 145,000 Australians will be diagnosed with cancer. At ACRF it is our mission to back brilliant research by giving scientists the technology and equipment to find ways to prevent, detect and treat cancer. 

Help us continue to fund life-saving cancer research by donating today.  

Sources:

Vulvar Cancer: Symptoms & Treatment

What are the symptoms of Vulvar Cancer?

The vulva is the external part of a woman’s sex organs. Vulvar cancer symptoms can include:

  • A lasting itch
  • Pain or soreness
  • Thickened, raised, red, white or dark patches on the skin of the vulva
  • Changes in the skin of the vulva, including colour changes or growths that look like a wart or ulcer 
  • An open sore or growth visible on the skin
  • Burning pain when you pass urine
  • Vaginal discharge or bleeding
  • A mole on the vulva that changes shape or colour
  • A lump or swelling in the vulva
  • A lump in the groin

All these symptoms can be caused by other conditions, such as infection but if you have any of these symptoms, you should see your doctor.

What is Vulvar Cancer? 

Vulvar cancer occurs when abnormal cells in the tissues of the vulva grow in an uncontrolled way. It can also be called cancer of the vulva, vulval cancer or vulva cancer.

The vulvar is the external part of a woman’s sex organs and consists of soft fatty tissue covered with pubic hair called the Mons Pubis, the labia – consisting of the two outer larger lips (the labia majora), two inner smaller and thinner lips (the labia minora), the clitoris and the perineum (the skin between the vulva and anus).

Cancer of the vulvar may involve any of these external female sex organs. The most common areas for it to develop are the inner edges of the labia majora and the labia minora.

Less often, vulvar cancer may also involve the clitoris or the Bartholin’s glands (small glands, one on each side of the vagina). It can also affect the perineum.

What are the causes of Vulvar Cancer? 

Usually, it is not possible to determine what exactly causes vulvar cancer in a particular woman but known risk factors include:

  • Being older, vulvar cancer is most common in women aged over 60
  • Having had the human papillomavirus (HPV) or genital warts
  • Smoking
  • If you have the skin conditions vulvar intraepithelial neoplasia or lichen sclerosus or if your vulva is often itchy
  • Previously having vaginal or cervical cancer
  • Radiotherapy to your pelvis in the past.

You can read more about vulvar cancer here.

So can you treat Vulvar Cancer? 

Yes, the main treatments used for vulvar cancer are surgery, radiotherapy and sometimes chemotherapy. A combination of treatments may be suggested depending on the type of cancer, where it is and your general health.

What treatment options are available for Vulvar Cancer? 

Surgery 

Surgery options for vulvar cancer include:

  • Wide local excision: In this procedure, the area containing the cancer is removed along with a border of healthy tissue around it. The important thing is to also remove a border of tissue that is free of cancer cells as this lowers the risk of the cancer coming back.

Sometimes surgeons use a laser to destroy abnormal cells. A laser is a thin, high powered beam of light that your surgeon can use instead of a surgical blade (scalpel).

  • Partial vulvectomy: In this procedure you may only need to have just the inner or outer labia removed, or the labia may be removed from one side only. The extent of surgery will depend on where the cancer is, and on how accessible a border of healthy tissue is for the surgeon to work with.
  • Vulvectomy (or radical vulvectomy): The whole vulva is removed, including the inner and outer lips of the vagina. The clitoris may be removed as well.
  • Lymph node dissection: The lymph nodes on one or both sides of the groin may be removed. The lymph nodes in the groin are usually the first place where cancer cells spread from the vulva. Removing them makes it less likely that the cancer will return. Whether the nodes are taken from one or both sides will depend on the size and position of the cancer.

Staging

The stage of vulvar cancer and grade of the cancer cells can be determined through testing. Depending on the relative size of the cancer, how far it has spread and how quickly it may develop, your health practitioner will recommend the most appropriate treatment. This may involve surgery, radiotherapy, chemotherapy or a combination.

Radiotherapy 

Radiotherapy uses radiation to kill or damage cancer cells. The use of this treatment for vulvar cancer depends on the stage and size of the cancer, as well as whether it has spread to the lymph nodes. This form of treatment may be given instead of, or in combination with, surgery. 

Chemotherapy

Chemotherapy destroys or slows the growth of cancer cells through the use of specialised drugs. It is commonly given by injection but can also be administered in a tablet or cream form. Chemotherapy may be given to control cancer which has spread, in conjunction with radiotherapy or as palliative treatment to help with symptom relief. 

Can you prevent Vulvar Cancer?

Not smoking and immunisation against HPV may help to reduce the likelihood of developing vulvar cancer. 

Donate to ACRF to back brilliant cancer research

ACRF is committed to backing the brilliant ideas needed to find pathbreaking ways to prevent, detect and treat all types of cancer, including vulvar cancer, so that we can create better outcomes for all Australians. 

By donating to ACRF, you are helping to provide scientists with the tools, technology and infrastructure they need to accelerate cancer research.

Sources: 

Running The Sydney Morning Herald Half Marathon for Cancer Research

On Sunday 15 May The Sydney Morning Herald Half Marathon will return after a three-year hiatus, and 32-year-old Jess Damerst from Redfern will be one of the thousands on the start line. 

Every athlete has their reason for running but for Jess, leveraging the half marathon as a fundraiser for the Australian Cancer Research Foundation (ACRF) is extra motivation. 

Cancer has had a major impact on Jess and the people in her life. In 2011 her dad was diagnosed with non-Hodgkin lymphoma and was initially given a 70% survival chance. Unfortunately, despite catching and treating the cancer early, it kept coming back and eventually he passed away in 2014 after a year and nine-month battle. 

Nearly three years later cancer struck again. Jess’ best friend Julie was diagnosed with ovarian cancer and underwent several rounds of chemotherapy as well as experimental therapies including immunotherapy. Julie ultimately passed away in October last year. 

Running has always been something Jess has used to clear her mind and help relieve day-to-day pressures. Jess says she also uses running as a way to remain close to those she’s lost. 

“My dad was a huge supporter of my running, always at the finish line or taking pictures, and then my friend Julie ran a half marathon with me in 2015 and she joined me in becoming a runner after that. She started running a lot and I remember running was a big part of what she wanted to do to stay healthy while she was on her journey with cancer,” said Jess. 

Jess first came across ACRF while looking for fundraising opportunities for The Sun-Herald City2Surf. Jess says both her dad and best friend were able to prolong their lifespan because of the advancements in cancer research, prevention, and lifesaving technologies, and so was drawn to ACRF as she felt their work was impactful in the cancer research space. 

“I’ve unfortunately been closely impacted by cancer, not in a positive way either as I’m only close to one person who has survived. But for my dad and best friend, unfortunately they weren’t able to find a cure,” she said. “I found ACRF because I was looking through fundraising opportunities for the City2Surf and I read their mission statement and I really liked the idea that the money was all toward lifesaving research and that felt really impactful for me personally.” 

After she ran the City2Surf, the charity invited Jess to see the equipment her fundraising had helped purchase. This gesture and show of attention to fundraisers cemented her support of ACRF and so Jess was determined to raise more money in support of the charity. 

With her sights set on The Sydney Morning Herald Half Marathon in May, Jess has already exceeded her initial fundraising target of $3,500 with a month to go until the event. 

With the onset of the COVID-19 pandemic, this will be Jess’ first event since 2019. In that time, she welcomed her first baby into the world in August last year. She says Sydney’s iconic half marathon is a great motivator to remain mentally and physically healthy. 

“Running is really ingrained in a lot of things around my interpersonal relationships and my health. I had a baby last August and so I thought that turning out for this event will be a really great motivator for me to get out and start working out again, and start with something that I’m familiar with,” said Jess. “I don’t do anything by halves, so I thought I’d do a half marathon.” 

On Sunday 15 May Jess will take to the streets of Sydney, running for herself, her son, and in support of a cancer-free world. 

“I’m sure I’ll feel everything. Every time I do a difficult running event, I do feel like it’s hard work but really gratifying when I do it,” she said. “Also raising money helps of course because I feel like the money is really going toward lifesaving research, and some of the more experimental stuff that helped my dad draw out his life for a couple of months and same with my friend, a lot of that stuff is now at the forefront of cancer cures.” 

Joining Jess for the half marathon are two of her ACRF fundraising teammates, Clare and Will, who have also lost friends and family to cancer. 

To donate to ACRF and support Jess Damerst’s fundraising effort visit https://smhhalfmarathon2022.grassrootz.com/acrf/jessica-damerst 

To enter The Sydney Morning Herald Half Marathon and for more information visit 2022 Sydney Morning Herald Half Marathon (grassrootz.com)

This article was originally created by The IRONMAN Group Oceania .

ACRF launches Inaugural 2km A Day in May Challenge

Australian Cancer Research Foundation (ACRF) has launched its inaugural 2km A Day in May challenge, encouraging Australians to get active each day to raise vital funds for life-saving cancer research.

2km A Day in May runs for the entire month of May, aiming to raise $250,000. This fun campaign, encourages people to get outdoors, live a healthy lifestyle and exercise. Whether that’s walking with friends or your pooch, running or cycling as long as you get active for at least 2km per day.

ACRF’s CEO, Kerry Strydom said, Australian Cancer Research Foundation backs brilliant cancer research and cutting-edge technology that drives innovation and ultimately – helps to save millions of lives.

“Fundraising campaigns such as ‘2km A Day in May’ helps us raise essential funds that allows us to back cancer research projects that push boundaries and blaze new trails,” said Kerry. “We’re encouraging all Aussies to get behind this new initiative, it’s a fun campaign that you can do with friends or on your own. Together we can unite as a community, raise vital funds that bring us closer to a world without cancer.” Participants can register or donate to 2km a Day in May here.